Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 1/2016

01-01-2016 | UNM Clinical Case Conferences

Obscure Occult GI Bleeding: An Iatrogenic Tale?

Authors: Ahmed Deabes, Michael Gavin

Published in: Digestive Diseases and Sciences | Issue 1/2016

Login to get access

Excerpt

A 63-year-old female nurse-anesthetist was initially evaluated in the outpatient clinic with a 4-week history of intermittent mid-epigastric abdominal pain that was colicky, often postprandial, non-radiating and would usually last for 15–30 min. Her symptoms were associated with intermittent postprandial nausea and abdominal distension. She denied any history of melena, hematochezia, constipation, diarrhea, or excess of flatus. Her appetite was decreased but without weight loss. On review of systems, she had noted some recent fatigue but denied any fevers, chills, or night sweats. …
Literature
1.
McCarthy DM. Nonsteroidal anti-inflammatory drugs—the clinical dilemmas. Scand J Gastroenterol. 1992;27:9–16.CrossRef
2.
Bjarnason I, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine. Gastroenterology. 1993;104:1832–1847.PubMed
3.
Bjarnason I, Ansell B. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet. 1984;2:1171–1173.PubMedCrossRef
4.
Goldstein JL. Videocapsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omperazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133–141.PubMedCrossRef
5.
Levi S, DeLacey G, Price AB, et al. ‘Diaphragm like’ strictures of the small bowel in patients treated with non-steroidal anti-inflammatory drugs. Br J Radiol. 1990;63:186–189.PubMedCrossRef
6.
Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet. 1991;337:520.PubMedCrossRef
7.
Hara AK, Fleischer DE. Imaging of small bowel disease: comparison of capsule endoscopy, standard endoscopy, barium examination, and CT, May–June 2005, vol 25, issue 3 RSNA 2005.
8.
Niwa Y, Nakamura M, Ohmiya N, Maeda O, et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol. 2008;43:270–276.PubMedCrossRef
9.
Bjarnason I, Gumpel MJ. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1992;33:1204–1208.PubMedPubMedCentralCrossRef
10.
Inoue T, Higashiyama M, Kaji I, et al. Dipeptidyl peptidase IV inhibition prevents the formation and promotes the healing of indomethacin-induced intestinal ulcers in rats. Dig Dis Sci. 2014;59:1286–1295.PubMedPubMedCentralCrossRef
Metadata
Title
Obscure Occult GI Bleeding: An Iatrogenic Tale?
Authors
Ahmed Deabes
Michael Gavin
Publication date
01-01-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3957-5

Other articles of this Issue 1/2016

Digestive Diseases and Sciences 1/2016 Go to the issue

Review

Helicobacter Pylori Infection: Diagnostic Strategies in Primary Diagnosis and After Therapy

Original Article

An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn’s Disease

Original Article

Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina

Original Article

Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission

Original Article

Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients

Editorial

Prevention of NSAID-Enteropathy: A Soluble Problem?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits